Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;20(1):100-111.
doi: 10.1016/j.hrthm.2022.08.011. Epub 2022 Aug 18.

Neuromodulation therapy for atrial fibrillation

Affiliations
Review

Neuromodulation therapy for atrial fibrillation

Maham F Karatela et al. Heart Rhythm. 2023 Jan.

Abstract

Atrial fibrillation has a multifactorial pathophysiology influenced by cardiac autonomic innervation. Both sympathetic and parasympathetic influences are profibrillatory. Innovative therapies targeting the neurocardiac axis include catheter ablation or pharmacologic suppression of ganglionated plexi, renal sympathetic denervation, low-level vagal stimulation, and stellate ganglion blockade. To date, these therapies have variable efficacy. As our understanding of atrial fibrillation and the cardiac nervous system expands, our approach to therapeutic neuromodulation will continue evolving for the benefit of those with AF.

Keywords: Atrial fibrillation; Autonomics; Ganglionated plexi; Neurocardiac axis; Neuromodulation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Vagal versus Adrenergic Atrial Fibrillation, adapted from Coumel, et al. and de Vos, et al.
Figure 2.
Figure 2.
The anatomy of the cardiac autonomic ganglionated plexi, as discovered through anatomic dissection of canines (Armour et al., black ), anatomic dissection of human hearts (Pauza et al., blue , ), and electroanatomic mapping of human hearts (Po et al., green ). (A) Posterior, (B) Cross-sectional, (C) Right, (D) Left. Abbreviations: Armour et al., PL-LAGP=posterolateral left atrial, OMGP=obtuse marginal, SLAGP=superior left atrial, PDGP=posterior descending, PM-LAGP=posteromedial left atrial, PRAGP=posterior right atrial, SRAGP=superior right atrial; Po et al., SLGP=superior left, ILGP=inferior left, ARGP=anterior right, IRGP=inferior right; Pauza et al., MDsGP=middle dorsal ganglionated subplexus, LDsGP=left dorsal ganglionated subplexus, VLAsGP=ventral left atrial ganglionated subplexus, DRAsGP=dorsal right atrial ganglionated subplexus, VRAsGP=ventral right atrial ganglionated subplexus, LCsGP=left coronary ganglionated subplexus, RCsGP=right coronary ganglionated subplexus. Anatomy: SVC=superior vena cava, PA=pulmonary artery, LAA=left atrial appendage, VOM=vein of Marshall, LSPV=left superior pulmonary vein, LIPV=left inferior pulmonary vein, RSPV=right superior pulmonary vein, RIPV=right inferior pulmonary vein, IVC=inferior vena cava, SA=sinoatrial, AV=atrioventricular.
Figure 3.
Figure 3.
Therapeutic Modulation of the Neurocardiac Axis.

Similar articles

Cited by

References

    1. Staerk L, Wang B, Preis SR, et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors. BMJ Apr 26 2018;361:k1453. - PMC - PubMed
    1. Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of Atrial Fibrillation in the 21st Century. Circulation Research 2020;127:4–20. - PMC - PubMed
    1. Bhatt HV, Fischer GW. Atrial Fibrillation: Pathophysiology and Therapeutic Options. J Cardiothorac Vasc Anesth 2015;29:1333–1340. - PubMed
    1. de Vos CB, Nieuwlaat R, Crijns HJGM, et al. Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation. EHJ 2008;29:632–639. - PubMed
    1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. JACC 2014;64:e1–e76. - PubMed

Publication types